Related Experiment Video
Updated: Sep 9, 2025

Rapid, Seamless Generation of Recombinant Poxviruses using Host Range and Visual Selection
Published on: May 24, 2020
MERS-CoV antagonizes PKR activation by inhibiting its condensation at viral replication complexes
Ebba K Blomqvist1,2,3, Nicole Bracci4,5, Helena Winstone4,5
1Department of Molecular Medicine, The Herbert Wertheim University of Florida Scripps Institute for Biomedical Innovation and Technology, Jupiter, FL, USA.
Abstract:
Middle East respiratory syndrome coronavirus (MERS-CoV) is a highly pathogenic virus that antagonizes innate immune responses, including the protein kinase R (PKR) pathway. Here, we examine the process of PKR activation in response to an immunostimulatory MERS-CoV mutant encoding an inactive endoribonuclease U and a deletion of accessory protein NS4a. We show that PKR condenses and activates on viral dsRNA proximal to viral double-membrane vesicles (DMVs). Condensates composed of activated PKR disassociate from dsRNA and dissolve, releasing activated PKR molecules into the cytosol where they phosphorylate eIF2α to initiate the integrated stress response. MERS-CoV NS4a protein prevents PKR activation by condensing on dsRNA and occluding PKR binding. Lastly, PKR condensation coincided with its activation in response to Zika virus. These findings establish a comprehensive model for PKR activation in response to positive-strand RNA viruses that replicate within membrane-associated complexes and elucidate how MERS-CoV antagonizes this crucial antiviral pathway.
Insights
Middle East respiratory syndrome coronavirus (MERS-CoV) antagonizes the protein kinase R (PKR) pathway. MERS-CoV NS4a protein prevents PKR activation by blocking PKR condensation on viral dsRNA, a crucial step for innate immunity.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- Middle East respiratory syndrome coronavirus (MERS-CoV) is a pathogenic virus that suppresses innate immune responses.
- The protein kinase R (PKR) pathway is a key component of the innate immune system targeted by MERS-CoV.
Purpose of the Study:
- To investigate the mechanism of PKR activation in response to MERS-CoV.
- To elucidate how MERS-CoV antagonizes the PKR pathway.
Main Methods:
- Utilized an immunostimulatory MERS-CoV mutant with an inactive endoribonuclease U and a deletion of accessory protein NS4a.
- Observed PKR condensation and activation on viral dsRNA associated with double-membrane vesicles (DMVs).
- Examined the role of MERS-CoV NS4a protein in PKR inhibition.
Main Results:
- PKR activates by condensing on viral dsRNA near DMVs, then dissociates to phosphorylate eIF2α.
- MERS-CoV NS4a protein inhibits PKR activation by binding to dsRNA and preventing PKR condensation.
- PKR condensation and activation were also observed in response to Zika virus.
Conclusions:
- PKR activation involves condensation on viral dsRNA at replication complexes, followed by autophosphorylation and cytosolic relocalization.
- MERS-CoV NS4a antagonizes this antiviral pathway by inhibiting PKR condensation.
- This study provides a model for PKR activation by positive-strand RNA viruses and MERS-CoV's immune evasion strategy.
More Related Videos
Related Concept Videos
Inhibition of Cdk Activity
MAPK Signaling Cascades
cAMP-dependent Protein Kinase Pathways
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
GPCR Desensitization
GPCRs Regulate Adenylyl Cylase Activity

